Status:
COMPLETED
Genotropin Study Assessing Use of Injection Pen
Lead Sponsor:
Pfizer
Conditions:
Growth Hormone Deficiency
Idiopathic Short Stature
Eligibility:
All Genders
8-18 years
Phase:
PHASE3
Brief Summary
Assessment of Genotropin patient and caregiver (Dyad) perception of convenience and preference of Genotropin injection pen. Patients already on genotropin will be asked to use a genotropin pen for 2 m...
Eligibility Criteria
Inclusion
- Age 8-18 years
- Using genotropin pen for at least 3 months prior to study enrollment
- Compliance with genotropin treatment
Exclusion
- Medical conditions that can affect participation in study
- Insufficient command of English language to understand questionnaire
- Using other growth hormone device and not Genotropin pen
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT00965484
Start Date
October 1 2009
End Date
January 1 2010
Last Update
January 28 2011
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Los Angeles, California, United States, 90048
2
Pfizer Investigational Site
San Diego, California, United States, 92123-4282
3
Pfizer Investigational Site
Greenwood Village, Colorado, United States, 80111
4
Pfizer Investigational Site
Gainesville, Florida, United States, 32608